Oculis announces R&D Retina Day, showcasing global experts in clinical programs

A panel of experts will answer questions about DME, CME, AON and more. Image credit: ©alphaspirit – stock.adobe.com

In July, biopharmaceutical company Oculis Holding AG will hold its first R&D Day to highlight its clinical developments in retina care. In a press release, the company, headquartered in Switzerland, announced a live event in New York City which will also be broadcast online.¹ The in-person and online showcase will be held Tuesday, 11 July, from 10_AM to 12_PM EDT.

Retina specialists will participate in presentations and a panel discussion. Topics that appear on the day's agenda include Diabetic Macular Edema (DME), Cystoid Macular Edema (CME) and Acute Optic Neuritis (AON).¹ The news release also included details of the clinical programming Oculis will showcase during the event, which include:

• OCS-01 DME DIAMOND programme: The recent Stage 1 read-out of the DIAMOND trial and plans for the upcoming DIAMOND 1 and DIAMOND 2 trials¹
• OCS-01 CME LEOPARD trial: The PoC LEOPARD trial initiation of OCS-01 eye drops in CME¹
• OCS-05 AON ACUITY trial: The ongoing PoC ACUITY trial of OCS-05, a neuroprotective candidate with a novel mechanism of action, in Acute Optic Neuritis¹

Oculis also released a list of specialists and researchers who will participate in the day’s events. Presenters expected to appear include Sophie Bonnin, MD, neuro-retina specialist at the Foundation Rothschild Hospital, Paris; David S. Boyer, MD, University of Southern California Keck School of Medicine; Quan Dong Nguyen, MD, MSc, FARVO, FASRS, Byers Eye Institute, Stanford University School of Medicine; and Arshad M. Khanani, MD, MA, FASRS, University of Nevada, Reno School of Medicine.

Panelists in the Q&A session will include Pravin Dugel, MD, president of Iveric Bio; Sabri Markabi, MD, an independent R&D consultant; Ramin Tadayoni, MD, professor of ophthalmology at University of Paris; and Pablo Villoslada, MD, adjunct professor at Stanford University. Oculis CEO, Riad Sherif, MD, will lead the discussion; Bastian Dehmel, MD, head of development at Oculis, will also answer questions.

Registration is free through the Oculis website. The in-person event takes place at the Lotte New York Palace Hotel. The registration page includes a submission form so attendees may ask the panelists questions.

Reference

1. Oculis to Host an R&D Retina Day to Showcase Clinical Programs Targeting Diabetic Macular Edema and Other Retina Diseases on Tuesday, July 11, 2023. News release. Oculis SA, June 26, 2023. https://www.globenewswire.com/news-release/2023/06/26/2694396/0/en/Oculis-to-Host-an-R-D-Retina-Day-to-Showcase-Clinical-Programs-Targeting-Diabetic-Macular-Edema-and-Other-Retina-Diseases-on-Tuesday-July-11-2023.html